MAVERICK CAPITAL LTD
Q2 2023 13F-HR Holdings
Net value change ($000)
+739,755
(18.7%)
New positions
129
Sold out positions
186
Turnover %
18.7%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| CPNG | 195,417 | 16.4% |
| STZ | 145,739 | NEW |
| BAX | 126,068 | NEW |
| DASH | 73,102 | 14418.5% |
| BK | 69,957 | 12294.7% |
| NVDA | 62,548 | 48.6% |
| HUM | 53,655 | 11513.9% |
| PM | 44,711 | NEW |
| NU | 44,489 | 72.7% |
| ImmunoGen, Inc. | 41,290 | 136.9% |
Top Reduces (Value $000, Stocks/ETFs)
| CRM | -84,851 | -48.7% |
| Catalent, Inc. | -69,387 | -100.0% |
| UNH | -62,642 | -99.5% |
| ANET | -48,279 | -98.6% |
| XP | -35,011 | -100.0% |
| LRCX | -32,821 | -64.4% |
| WDAY | -32,755 | -33.0% |
| Ferguson (Jersey) Ltd | -24,012 | -100.0% |
| CBRE | -23,906 | -40.5% |
| MELI | -23,727 | -36.6% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
3,691
(0.1% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|